Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study
about
How and When to Screen for Atrial Fibrillation after Stroke: Insights from Insertable Cardiac Monitoring DevicesDiagnosis, prognosis, and management of cryptogenic strokeImpact of valvular thickness on stroke recurrence in medically treated patients with strokeSignatures of cardioembolic and large-vessel ischemic stroke.Cryptogenic stroke: A diagnostic challengeSmall vessel cerebrovascular disease: the past, present, and future.Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Treatment of Rivaroxaban versus Aspirin for Non-disabling Cerebrovascular Events (TRACE): study protocol for a randomized controlled trial.Comparative sensitivity of computed tomography vs. magnetic resonance imaging for detecting acute posterior fossa infarct.Potential new uses of non-vitamin K antagonist oral anticoagulants to treat and prevent stroke.Intracranial atherosclerotic disease; current options for surgical or medical treatment.Recurrent Embolic Strokes of Undetermined Source in a Patient with Extreme Lipoprotein(a) LevelsRecurrent stroke: where do we stand with the secondary prevention of noncardioembolic ischaemic strokes?Towards evidence-based treatment of thrombotic antiphospholipid syndrome.Direct thrombin inhibitors and factor Xa inhibitors in patients with cerebrovascular disease.Challenges of older patients' knowledge about warfarin therapy.Cryptogenic stroke: how to define it? How to treat it?Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SAtrial fibrillation and risk of stroke: a nationwide cohort study.Undetermined stroke with an embolic pattern--a common phenotype with high early recurrence risk.High Incidence of Atrial Fibrillation After Embolic Stroke of Undetermined Source in Posterior Cerebral Artery Territory.Aspirin plus dipyridamole has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of cerebral infarction.Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial
P2860
Q26747267-1C1628EB-CE2E-439F-B23C-A573E711867AQ26766106-A3F2BA38-DCF6-4D86-9029-0D914302387CQ28221124-44FFF74C-0076-45B6-95B9-C7D70CDEFB1AQ34257962-F8106439-675D-406A-9CF7-7C7B4302E1D8Q34335867-C4907C04-658D-4FD2-9AE6-5D2906391171Q35725548-BCDFD611-E96D-4B31-9DD1-CE6BB6B38418Q35752603-3FE82865-2F8C-4475-BC18-33F5C04394A9Q35803734-9A48EE1C-ABAA-4282-83FE-285B02CB64D7Q35942025-09E5BD91-059F-475E-9554-EB65F0B4F252Q36155695-B6D7CA39-6F5C-4BB3-B30A-F4D3A56C4C94Q36985916-BD65D456-BD53-4B09-88BB-3EC0FAB8426AQ37218193-E33E8A76-CCC2-47FD-8472-5EA69CD85868Q37362773-F7FE55DE-FD79-4FFE-BCF0-6E890205F249Q37721614-A02BF193-A58D-4789-8C34-0A7B4407C1D1Q37979872-8287C19D-C70F-4653-AD7D-761318C40E2FQ38117337-C339AF95-234C-46D7-8989-FF7CA667B6FCQ38150761-BECF486F-EA55-42A7-9C2A-7733363F8065Q40485244-08928002-1D4D-4D40-B014-80DAE8768CA3Q40496126-61EB4312-F45A-4532-8448-483E63E46F0BQ41532441-D1D4DB38-E11D-47F2-8E64-075CCBE6CBDCQ47395553-AA75F98C-F811-4D01-80D5-07D7C7961DE3Q55003714-F3634ACF-514D-4BC1-9CF9-531246A0750CQ57312989-9A24AD86-6AB1-42DA-84EC-6B2875A5FDF8
P2860
Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study
description
2006 nî lūn-bûn
@nan
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Comparison of warfarin versus ...... Aspirin Recurrent Stroke Study
@ast
Comparison of warfarin versus ...... Aspirin Recurrent Stroke Study
@en
Comparison of warfarin versus ...... Aspirin Recurrent Stroke Study
@nl
type
label
Comparison of warfarin versus ...... Aspirin Recurrent Stroke Study
@ast
Comparison of warfarin versus ...... Aspirin Recurrent Stroke Study
@en
Comparison of warfarin versus ...... Aspirin Recurrent Stroke Study
@nl
prefLabel
Comparison of warfarin versus ...... Aspirin Recurrent Stroke Study
@ast
Comparison of warfarin versus ...... Aspirin Recurrent Stroke Study
@en
Comparison of warfarin versus ...... Aspirin Recurrent Stroke Study
@nl
P2093
P2860
P3181
P356
P1476
Comparison of warfarin versus ...... Aspirin Recurrent Stroke Study
@en
P2093
Amy Murphy
Bruce Levin
J L P Thompson
Robert R Sciacca
Shyam Prabhakaran
P2860
P3181
P356
10.1159/000092331
P407
P577
2006-01-01T00:00:00Z